There are nevertheless concerns that in vivo, nanomaterials containing TSH, the natural agonist of TSHR, may promote the proliferation and dissemination of thyroid cancer cells through mechanisms such as activation of the cAMP pathway. The gene discussed is TSHR; the disease is thyroid cancer.